Structural modifications enhance enzymatic resistance, particularly against dipeptidyl peptidase-4 (DPP-4)
On the clinical side, cost remains the main access barrier
Moreover, zinc supplementation has been shown to reduce systolic blood pressure, highlighting its potential therapeutic role in managing hypertension [457]
The mental health profiles of these newer medications are not yet well characterized
Rather than replacing conventional approaches entirely, it often enhances their effectiveness and accelerates recovery timelines
Genel olarak vcut kitle indeksi 30 ve zeri olan bireyler veya vcut kitle indeksi 27 ve zeri olup tip 2 diyabet, hipertansiyon, inslin direnci gibi ek metabolik riskleri bulunan kiiler hekim deerlendirmesine alnabilir